Guoliang Li is a research associate at Meharry Medical College. He received a Ph.D. degree in 2007 from Wayne State University. His research interests involve a comprehensive understanding of key signaling pathways and their alterations contributing to human diseases. In his Ph.D. study, he investigated the oxidation of catecholamines and their involvement in the death of dopaminergic neurons leading to Parkinson’s disease. During his postdoctoral training, he studied the contributions of genetic variations to cancer incidence and development, which include single nucleotide polymorphisms, DNA copy number variation, and microsatellite instability. Currently, his research is extended to the oncogenic role of lysine-specific demethylase KDM5B in prostate cancer progression.
Guoliang Li is a research associate at Meharry Medical College. He received a Ph.D. degree in 2007 from Wayne State University. His research interests involve a comprehensive understanding of key signaling pathways and their alterations contributing to human diseases. In his Ph.D. study, he investigated the oxidation of catecholamines and their involvement in the death of dopaminergic neurons leading to Parkinson’s disease. During his postdoctoral training, he studied the contributions of genetic variations to cancer incidence and development, which include single nucleotide polymorphisms, DNA copy number variation, and microsatellite instability. Currently, his research is extended to the oncogenic role of lysine-specific demethylase KDM5B in prostate cancer progression.